You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 193 No. 10, September 6, 1965 TABLE OF CONTENTS
  JAMA
  •  Online Features
  COUNCIL ON DRUGS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Antibiotic Dosage in Newborn and Premature Infants

Sumner J. Yaffe, MD

JAMA. 1965;193(10):818-820.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The intelligent use of a drug in any patient demands adequate knowledge of the mechanisms of absorption, metabolism, and excretion of the given agent, as well as its therapeutic actions and possible untoward effects. When antibiotic therapy is undertaken, another variable, the microorganism, is introduced. Determination of the therapeutic dosage of an antibiotic on a rational basis, which is mandatory in any case, requires recognition of the potential interplay among these entities.

After absorption, the concentration of an antibiotic agent is determined mainly by metabolism (detoxication) and excretion, which are fairly constant in the healthy adult, child, and older infant. In practice, therefore, antibiotic dosages for those beyond the neonatal period are usually achieved by adjusting adult dosage on the basis of age (Young's rule), body weight (or correction for body weight according to Clark's rule), or surface area.

However, because the neonatal period is one of changing body and . . . [Full Text PDF of this Article]


Author Affiliations

From the Department of Pediatrics, School of Medicine, State University of Buffalo, New York. Dr. Yaffe is a member of the Pediatrics Panel of the AMA Registry on Adverse Reactions.


Footnotes

This paper was invited by the Section on Adverse Reactions of the Council on Drugs.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1965 American Medical Association. All Rights Reserved.